A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients.
Haug CE, Colvin RB, Delmonico FL, Auchincloss H Jr, Tolkoff-Rubin N, Preffer FI, Rothlein R, Norris S, Scharschmidt L, Cosimi AB.
Haug CE, et al. Among authors: preffer fi.
Transplantation. 1993 Apr;55(4):766-72; discussion 772-3. doi: 10.1097/00007890-199304000-00016.
Transplantation. 1993.
PMID: 8097341
Clinical Trial.